ciprofloxacin has been researched along with Diarrhea in 191 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A single dose of ciprofloxacin was effective and safe in treating uncomplicated diarrhea among service members in Africa." | 9.69 | A single dose of ciprofloxacin reduces the duration of diarrhea among service members deployed in Africa. ( Aigle, L; Coton, T; Desplans, J; Le Dault, E; Marimoutou, C; Mayet, A; Savini, H; Sicard, S; Simon, F, 2023) |
| "The novel oral antibiotic formulation Rifamycin SV-MMX®, with a targeted delivery to the distal small bowel and colon, was superior to placebo in treating travellers' diarrhea (TD) in a previous study." | 9.27 | Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria. ( Araujo, P; DuPont, HL; Gracias Garcia, ML; Greinwald, R; Jiang, ZD; Nacak, T; Steffen, R; Stiess, M, 2018) |
| "Rifaximin was compared with placebo and ciprofloxacin for treatment of travelers' diarrhea in a randomized, double-blind clinical trial." | 9.12 | A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. ( Bourgeois, AL; Dupont, HL; Ericsson, CD; Haake, R; Halpern, J; Jiang, ZD; Steffen, R; Taylor, DN, 2006) |
| "Oral ciprofloxacin was as safe and effective as intramuscular ceftriaxone for the empiric treatment of acute invasive diarrhea in ambulatory pediatric patients requiring an emergency room visit." | 9.09 | Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. ( Dagan, R; Janco, J; Leibovitz, E; Piglansky, L; Press, J; Reinhart, H; Yagupsky, P; Yaniv, I, 2000) |
| "The purpose of this study was to determine the role of enteroaggregative Escherichia coli (EAEC) in the development of traveler's diarrhea and the clinical response of patients with EAEC diarrhea following treatment with ciprofloxacin." | 9.09 | Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. ( Adachi, JA; Ashley, D; DiCesare, D; DuPont, HL; Ericsson, CD; Glandt, M; Jiang, ZD; Mathewson, JJ, 1999) |
| "We conducted a randomized double-blinded study in Lima, Peru, to assess the tolerability and efficacy of a single 250-mg dose of ciprofloxacin in preventing diarrhea and Vibrio cholerae O1 infection among household contacts of bacteriologically confirmed index cases." | 9.08 | Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera. ( Carrillo, C; Echevarría, J; Gotuzzo, E; Mostorino, R; Ruiz, R; Seas, C, 1995) |
| "We evaluated the use of azithromycin (500 mg) or ciprofloxacin (500 mg) daily for 3 days for the treatment of acute diarrhea among United States military personnel in Thailand." | 9.08 | Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. ( Amato, S; Echeverria, P; Hoge, CW; Kuschner, RA; Olafson, RP; Pitarangsi, C; Sadoff, JC; Taylor, DN; Thomas, RJ; Trofa, AF, 1995) |
| "We conducted a randomized controlled trial to determine whether empirical treatment of severe acute community-acquired gastroenteritis (four fluid stools per day for > 3 days) with ciprofloxacin reduces the duration of diarrhea and other symptoms and to determine what effect ciprofloxacin has on the duration of long-term fecal carriage of gastrointestinal pathogens." | 9.08 | Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. ( Dryden, MS; Gabb, RJ; Wright, SK, 1996) |
| "To determine the efficacy of loperamide given with long- and short-course quinolone therapy for treating traveler's diarrhea, 142 US military personnel were randomized to receive a single 750-mg dose of ciprofloxacin with placebo, 750 mg of ciprofloxacin with loperamide, or a 3-day course of 500 mg of ciprofloxacin twice daily with loperamide." | 9.07 | Treatment of traveler's diarrhea with ciprofloxacin and loperamide. ( DeFraites, R; Echeverria, P; Gelnett, J; Haberberger, RL; Murphy, GS; Petruccelli, BP; Sanchez, JL; Taylor, DN; Walz, S, 1992) |
| " coli was the predominant cause of travelers' diarrhea, loperamide combined with ciprofloxacin was not better than treatment with ciprofloxacin alone." | 9.07 | Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. ( Candler, W; Echeverria, P; McQueen, C; Sanchez, JL; Taylor, DN; Thornton, S, 1991) |
| "To determine the efficacy, safety and effect on fecal flora of ciprofloxacin in the prevention of travelers' diarrhea, 54 volunteers traveling to Tunisia were randomized in a double-blind manner to receive either 500 mg ciprofloxacin or a placebo once daily for one week." | 9.06 | Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea. ( Beumer, H; Hoepelman, IM; Rademaker, CM; Rozenberg-Arska, M; Verhoef, J; Wolfhagen, MJ, 1989) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 9.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "In a double-blind, randomized trial, 85 adult patients with acute diarrhea (more than three watery stools per day) received either 500 mg of ciprofloxacin twice daily or placebo for five days." | 9.06 | Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. ( Diridl, G; Pichler, HE; Stickler, K; Wolf, D, 1987) |
| "The efficacy of ciprofloxacin was compared with that of trimethoprim-sulfamethoxazole in a placebo-controlled trial of the 5-day treatment of acute diarrhea among 181 adults recently arrived in Guadalajara, Mexico." | 9.06 | Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial. ( Bitsura, JA; de la Cabada, FJ; Dupont, HL; Ericsson, CD; Johnson, PC; Morgan, DR, 1987) |
| "Ciprofloxacin and other related fluorinated 4-quinolones have microbiological and pharmacokinetic properties that suggest they could be useful agents in the management of typhoid fever and bacterial gastroenteritis." | 8.78 | Treatment of typhoid fever and infectious diarrhoea with ciprofloxacin. ( Pithie, AD; Wood, MJ, 1990) |
| "Of the 24 patients with EHEC-associated diarrhea, seven received antibiotics before any signs of HUS were present (ciprofloxacin, cefotaxime, amoxicillin and/or metronidazole)." | 7.79 | Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea. ( Fritzsche, C; Geerdes-Fenge, HF; Henschel, J; Höhn, R; Koball, S; Löbermann, M; Mitzner, S; Nürnberg, M; Podbielski, A; Reisinger, EC; Schober, HC, 2013) |
| ", ciprofloxacin) are used to treat Campylobacter infections in adults." | 7.72 | Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. ( Angulo, FJ; Hoekstra, RM; Joyce, K; Kassenborg, HD; Marano, N; Nelson, JM; Rabatsky-Ehr, T; Segler, SD; Smith, KE; Vugia, DJ; Zansky, SM, 2004) |
| "Tosufloxacin (A-60969 HCl), a new quinolone with broad activity against gram-positive and anaerobic organisms, was compared in vitro with other quinolones against bacterial pathogens of diarrhea." | 7.68 | In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea. ( Bryan, JP; Krieg, RE; Perine, PL; Sheffield, J; Wagner, K; Waters, C, 1990) |
| "The in vitro activity of ciprofloxacin against bacterial enteropathogens isolated from cases of travellers' diarrhea in Egypt was compared to trimethoprim (TMP) and trimethoprim-sulfamethoxazole (SXT)." | 7.67 | In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt. ( Bourgeois, AL; Hyams, KC; Lissner, CR; Mikhail, IA; Podgore, JK; Walz, S, 1987) |
| "Rifaximin is a poorly absorbed rifamycin derivative under investigation for treatment of infectious diarrhea." | 6.70 | Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. ( Adachi, JA; Ashley, D; DuPont, HL; DuPont, MW; Ericsson, CD; Jiang, ZD; Martinez-Sandoval, F; Mathewson, JJ; Palazzini, E; Riopel, LM, 2001) |
| "Trimethoprim/sulfamethoxazole is currently considered the treatment of choice for shigellosis and severe travelers' diarrhea." | 6.16 | Current problems in antimicrobial therapy for bacterial enteric infection. ( DuPont, HL; Ericsson, CD; Johnson, PC; Robinson, A, 1987) |
| "A single dose of ciprofloxacin was effective and safe in treating uncomplicated diarrhea among service members in Africa." | 5.69 | A single dose of ciprofloxacin reduces the duration of diarrhea among service members deployed in Africa. ( Aigle, L; Coton, T; Desplans, J; Le Dault, E; Marimoutou, C; Mayet, A; Savini, H; Sicard, S; Simon, F, 2023) |
| "Ulifloxacin was highly active against Escherichia coli, Salmonella spp." | 5.35 | Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea. ( Biedenbach, DJ; Fritsche, TR; Jones, RN, 2009) |
| "Oral ciprofloxacin therapy was continued for 10 days and the patient remained free of symptoms with formed stools thereafter." | 5.29 | Pseudomonas aeruginosa as a cause of infectious diarrhea successfully treated with oral ciprofloxacin. ( Porco, FV; Visconte, EB, 1995) |
| "The novel oral antibiotic formulation Rifamycin SV-MMX®, with a targeted delivery to the distal small bowel and colon, was superior to placebo in treating travellers' diarrhea (TD) in a previous study." | 5.27 | Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria. ( Araujo, P; DuPont, HL; Gracias Garcia, ML; Greinwald, R; Jiang, ZD; Nacak, T; Steffen, R; Stiess, M, 2018) |
| "Rifaximin was compared with placebo and ciprofloxacin for treatment of travelers' diarrhea in a randomized, double-blind clinical trial." | 5.12 | A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. ( Bourgeois, AL; Dupont, HL; Ericsson, CD; Haake, R; Halpern, J; Jiang, ZD; Steffen, R; Taylor, DN, 2006) |
| "We conducted a double-blind, randomized trial comparing the equivalence of azithromycin and ciprofloxacin (each given in a single 1-g dose of two 500-mg tablets) among 195 men with severe cholera caused by Vibrio cholerae O1 or O139." | 5.12 | Single-dose azithromycin for the treatment of cholera in adults. ( Ahmed, S; Bennish, ML; Karim, MM; Khan, WA; Saha, D; Salam, MA, 2006) |
| "The purpose of this study was to determine the role of enteroaggregative Escherichia coli (EAEC) in the development of traveler's diarrhea and the clinical response of patients with EAEC diarrhea following treatment with ciprofloxacin." | 5.09 | Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. ( Adachi, JA; Ashley, D; DiCesare, D; DuPont, HL; Ericsson, CD; Glandt, M; Jiang, ZD; Mathewson, JJ, 1999) |
| "Oral ciprofloxacin was as safe and effective as intramuscular ceftriaxone for the empiric treatment of acute invasive diarrhea in ambulatory pediatric patients requiring an emergency room visit." | 5.09 | Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. ( Dagan, R; Janco, J; Leibovitz, E; Piglansky, L; Press, J; Reinhart, H; Yagupsky, P; Yaniv, I, 2000) |
| "To compare 1 week of trimethoprim-sulfamethoxazole treatment and 1 week of ciprofloxacin treatment in HIV-infected patients with chronic diarrhea caused by I." | 5.09 | Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. ( Fitzgerald, DW; Johnson, WD; Pape, JW; Verdier, RI, 2000) |
| "We conducted a randomized double-blinded study in Lima, Peru, to assess the tolerability and efficacy of a single 250-mg dose of ciprofloxacin in preventing diarrhea and Vibrio cholerae O1 infection among household contacts of bacteriologically confirmed index cases." | 5.08 | Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera. ( Carrillo, C; Echevarría, J; Gotuzzo, E; Mostorino, R; Ruiz, R; Seas, C, 1995) |
| "We evaluated the use of azithromycin (500 mg) or ciprofloxacin (500 mg) daily for 3 days for the treatment of acute diarrhea among United States military personnel in Thailand." | 5.08 | Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. ( Amato, S; Echeverria, P; Hoge, CW; Kuschner, RA; Olafson, RP; Pitarangsi, C; Sadoff, JC; Taylor, DN; Thomas, RJ; Trofa, AF, 1995) |
| "We conducted a randomized controlled trial to determine whether empirical treatment of severe acute community-acquired gastroenteritis (four fluid stools per day for > 3 days) with ciprofloxacin reduces the duration of diarrhea and other symptoms and to determine what effect ciprofloxacin has on the duration of long-term fecal carriage of gastrointestinal pathogens." | 5.08 | Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. ( Dryden, MS; Gabb, RJ; Wright, SK, 1996) |
| "Loperamide decreases the number of unformed stools and shortens the duration of diarrhea in dysentery caused by Shigella in adults treated with ciprofloxacin." | 5.07 | Ciprofloxacin and loperamide in the treatment of bacillary dysentery. ( Bodhidatta, L; Echeverria, P; Hoge, CW; Imlarp, S; Murphy, GS; Tamura, K; Tansuphaswadikul, S, 1993) |
| "To determine the efficacy of loperamide given with long- and short-course quinolone therapy for treating traveler's diarrhea, 142 US military personnel were randomized to receive a single 750-mg dose of ciprofloxacin with placebo, 750 mg of ciprofloxacin with loperamide, or a 3-day course of 500 mg of ciprofloxacin twice daily with loperamide." | 5.07 | Treatment of traveler's diarrhea with ciprofloxacin and loperamide. ( DeFraites, R; Echeverria, P; Gelnett, J; Haberberger, RL; Murphy, GS; Petruccelli, BP; Sanchez, JL; Taylor, DN; Walz, S, 1992) |
| " coli was the predominant cause of travelers' diarrhea, loperamide combined with ciprofloxacin was not better than treatment with ciprofloxacin alone." | 5.07 | Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. ( Candler, W; Echeverria, P; McQueen, C; Sanchez, JL; Taylor, DN; Thornton, S, 1991) |
| "From June 1985 to September 1987, 202 adults were enrolled in a randomized, double-blinded study comparing ciprofloxacin (500 mg) with sulfamethoxazole and trimethoprim (160 mg/800 mg) or placebo for adults with acute diarrhea." | 5.06 | Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. ( Goodman, LJ; Hines, D; Kaplan, RL; Landau, W; Mayer, KW; Nelson, JA; Parkhurst, GW; Petrak, R; Segreti, J; Trenholme, GM, 1990) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 5.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "The efficacy of ciprofloxacin was compared with that of trimethoprim-sulfamethoxazole in a placebo-controlled trial of the 5-day treatment of acute diarrhea among 181 adults recently arrived in Guadalajara, Mexico." | 5.06 | Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial. ( Bitsura, JA; de la Cabada, FJ; Dupont, HL; Ericsson, CD; Johnson, PC; Morgan, DR, 1987) |
| "In a double-blind, randomized trial, 85 adult patients with acute diarrhea (more than three watery stools per day) received either 500 mg of ciprofloxacin twice daily or placebo for five days." | 5.06 | Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. ( Diridl, G; Pichler, HE; Stickler, K; Wolf, D, 1987) |
| "Ciprofloxacin and other related fluorinated 4-quinolones have microbiological and pharmacokinetic properties that suggest they could be useful agents in the management of typhoid fever and bacterial gastroenteritis." | 4.78 | Treatment of typhoid fever and infectious diarrhoea with ciprofloxacin. ( Pithie, AD; Wood, MJ, 1990) |
| "This study was aimed at investigating the occurrence and genetic mechanisms of resistance to ciprofloxacin, tetracycline and erythromycin in clinical isolates of Campylobacter jejuni recovered from human cases of acute gastroenteritis in Turkey." | 3.91 | Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey. ( Abay, S; Aydin, F; Kayman, T; Şahin, O, 2019) |
| "Emergence of ciprofloxacin resistant ETEC strains results in a major challenge in current treatment strategies of ETEC diarrhea." | 3.83 | Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh. ( Azmi, IJ; Begum, YA; Qadri, F; Shahnaij, M; Sharmin, S; Sheikh, A; Svennerholm, AM; Talukder, KA, 2016) |
| "Ciprofloxacin, ceftriaxone, and sulfamethoxazole/trimethoprim are suitable choices for the treatment of bacterial acute diarrhea." | 3.83 | Characteristics of bacterial acute diarrhea among women. ( Antonello, VS; Dallé, J; Jimenez, MF; Kronbauer, K; Riche, CW; Rocha-Castro, J; Santiago, JA, 2016) |
| "Campylobacter was a major cause of diarrhea in children in two departments in Guatemala; antimicrobial resistance was high, and treatment regimens in the ambulatory setting which included metronidazole and trimethoprim-sulfamethoxazole and lacked oral rehydration were sub-optimal." | 3.80 | Burden of laboratory-confirmed Campylobacter infections in Guatemala 2008-2012: results from a facility-based surveillance system. ( Arvelo, W; Benoit, SR; Henao, O; Lindblade, K; Lopez, B; Moir, JC; Parsons, MB; Reyes, L, 2014) |
| "Of the 24 patients with EHEC-associated diarrhea, seven received antibiotics before any signs of HUS were present (ciprofloxacin, cefotaxime, amoxicillin and/or metronidazole)." | 3.79 | Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea. ( Fritzsche, C; Geerdes-Fenge, HF; Henschel, J; Höhn, R; Koball, S; Löbermann, M; Mitzner, S; Nürnberg, M; Podbielski, A; Reisinger, EC; Schober, HC, 2013) |
| "WHO recommends ciprofloxacin as the drug of choice for bloody diarrhea." | 3.79 | Clinical response to antibiotics among children with bloody diarrhea. ( Nujum, ZT; Purushothaman, KK; Sreenivasan, P, 2013) |
| "Twenty-eight of the 302 Salmonella strains isolated from patients with overseas travelers' diarrhea who were examined at Kansai Airport Department Station during the 6-year period between 2001 and 2007 showed decreased susceptibility to both nalidixic acid (NA) and ciprofloxacin (CPFX) (MIC of NA, 16-64 microg/mL; MIC of CPFX, 0." | 3.75 | Plasmid-mediated quinolone resistance in Salmonella isolated from patients with overseas travelers' diarrhea in Japan. ( Hayashi, A; Inoue, K; Kamakura, K; Kashiwagi, E; Kawahara, R; Seto, K; Taguchi, M; Yamagata, N, 2009) |
| "To provide information about the characteristics of diarrheal stool in multi-drug resistant typhoid fever and observe the clinical course after treatment with furazolidone or ciprofloxacin." | 3.69 | Multi-drug resistant typhoid fever with diarrhea. ( Bhattacharya, SK; Chatterjee, MK; Dutta, P; Garai, T; Manna, B; Mitra, U; Rasaily, R; Saha, MR; Sengupta, M, 1997) |
| "Ciprofloxacin may be considered as first-line treatment for a number of infections in which gram-negative pathogens are proven or strongly suspected, including complicated urinary tract infections, bacterial prostatitis, bacterial diarrhea, selected bone and joint infections, malignant otitis externa, bronchopulmonary infections in patients with cystic fibrosis and selected pneumonia cases." | 3.69 | Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society. ( Louie, TJ, 1994) |
| "Tosufloxacin (A-60969 HCl), a new quinolone with broad activity against gram-positive and anaerobic organisms, was compared in vitro with other quinolones against bacterial pathogens of diarrhea." | 3.68 | In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea. ( Bryan, JP; Krieg, RE; Perine, PL; Sheffield, J; Wagner, K; Waters, C, 1990) |
| "The in vitro activity of ciprofloxacin against bacterial enteropathogens isolated from cases of travellers' diarrhea in Egypt was compared to trimethoprim (TMP) and trimethoprim-sulfamethoxazole (SXT)." | 3.67 | In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt. ( Bourgeois, AL; Hyams, KC; Lissner, CR; Mikhail, IA; Podgore, JK; Walz, S, 1987) |
| "Rifaximin did not prevent campylobacteriosis in this controlled human infection model." | 2.87 | Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial. ( Alcala, A; Brubaker, J; Chakraborty, S; DeNearing, B; Gariepy, CL; Guerry, P; Gutierrez, RL; Harro, C; Jaep, K; Laird, RM; Maue, AC; Mochalova, Y; Poly, F; Porter, CK; Riddle, MS; Rimmer, JE; Sack, DA; Talaat, KR; Tribble, DR, 2018) |
| "Rifaximin is a poorly absorbed rifamycin derivative under investigation for treatment of infectious diarrhea." | 2.70 | Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. ( Adachi, JA; Ashley, D; DuPont, HL; DuPont, MW; Ericsson, CD; Jiang, ZD; Martinez-Sandoval, F; Mathewson, JJ; Palazzini, E; Riopel, LM, 2001) |
| "The ciprofloxacin was used as a second-shot therapy in patients which did not realt on routine three-drugs antibacterial management." | 2.69 | [Antibacterial treatment in patients after extended bowel resection with ileo-cecal valve removal--personal experience]. ( Karski, J; Karski, M; Misztal, M; Paluszkiewicz, P, 1998) |
| "Oral ciprofloxacin is a cost-effective prophylactic agent for high-risk ERCP." | 2.69 | Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients. ( Alveyn, CG; Davis, AJ; Kolios, G; Robertson, DA, 1998) |
| "It is likely that EAggEc are a treatable cause of diarrheal disease in some persons with HIV and no other apparent enteric pathogen." | 2.69 | Successful treatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus. ( Acheson, D; Blais, V; Gerrior, J; Mayer, H; Wanke, CA, 1998) |
| "Acute diarrhea is the most common illness that affects travelers to low-income regions of the world." | 2.52 | Traveler's diarrhea: a clinical review. ( DuPont, HL; Hill, DR; Steffen, R, 2015) |
| "Ciprofloxacin was offered to non-athlete team members as prophylaxis but not to athletes due to its possible association with tendon disease." | 2.45 | Setting standards for the prevention and management of travellers' diarrhoea in elite athletes: an audit of one team during the Youth Commonwealth Games in India. ( Loosemore, M; Tillett, E, 2009) |
| "Infectious diarrhea is a significant cause of morbidity and mortality and a common complaint in clinical practice." | 2.41 | The role of antibiotics in the treatment of infectious diarrhea. ( Oldfield, EC; Wallace, MR, 2001) |
| "A high prevalence of shigellosis continues in sub-Saharan Africa." | 1.91 | Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study. ( Antonio, M; Awuor, AO; Badji, H; Doh, S; Focht, C; Hossain, MJ; Houpt, E; Jones, J; Jones, JCM; Juma, J; Kasumba, IN; Kotloff, KL; Liu, J; Nasrin, D; Nasrin, S; Ochieng, JB; Omore, R; Permala-Booth, J; Platts-Mills, JA; Powell, H; Roose, A; Sen, S; Sow, SO; Sugerman, CE; Tennant, SM; Verani, JR; Watson, N; Widdowson, MA; Zaman, SMA, 2023) |
| "Antimicrobial resistance against shigellosis is increasingly alarming." | 1.72 | Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh. ( Ahmed, D; Ahmed, T; Alam, B; Chakraborty, S; Chisti, MJ; Das, R; Das, S; Faruque, ASG; Haque, MA; Islam, SB; Khan, SH; Nuzhat, S; Palit, P, 2022) |
| "Many cases of Clostridioides difficile infection (CDI) are poorly responsive to standard antibiotic treatment strategies, and often patients suffer from recurrent infections characterized by severe diarrhea." | 1.51 | Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile. ( Allen-Vercoe, E; Carlucci, C; Carriero, C; Daigneault, M; Jones, CS; Oliphant, K; Petrof, EO; Robinson, A; Weese, JS; Yen, S, 2019) |
| "However, Salmonella infections may induce elevated pancreatic enzyme levels without clinical pancreatitis or morphological pancreatic abnormalities through a variety of proposed mechanisms." | 1.46 | Salmonella colitis as an unusual cause of elevated serum lipase. ( Buchan, D; Dean, R; Gill, D, 2017) |
| "Travelers' diarrhea is self-limiting and generally resolves within 5 days; however, antibiotic treatment significantly reduces symptom severity and duration of illness." | 1.46 | Antibiotic Therapy for Acute Watery Diarrhea and Dysentery. ( Tribble, DR, 2017) |
| "Ciprofloxacin treatment reorganized microbiota populations; however, the original structure was largely restored at one and three month follow-up visits." | 1.43 | Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment. ( Astrovskaya, I; Bravo, HC; Chakraborty, S; Harro, C; Li, S; Lindsay, BR; Parkhill, J; Paulson, JN; Pop, M; Sack, DA; Stine, OC; Walker, AW; Walker, RI, 2016) |
| "Proper use of antibiotics in the treatment of acute diarrhea is crucial due to the high level of antibiotic resistance." | 1.43 | Viral and Bacterial Etiology of Acute Diarrhea among Children under 5 Years of Age in Wuhan, China. ( Cheng, ZJ; Li, S; Liu, WY; Sun, ZY; Tian, L; Xiang, X; Yu, WT; Zhang, WQ; Zhu, XH, 2016) |
| "Acute diarrhea is a leading cause of morbidity and mortality in children, particularly in those under the age of 5 years." | 1.43 | Characteristics of bacterial pathogens associated with acute diarrhea in children under 5 years of age: a hospital-based cross-sectional study. ( Chen, Z; Li, S; Liu, W; Sun, Z; Tian, L; Xiang, X; Yu, W; Zhang, W; Zhu, X, 2016) |
| "Ciprofloxacin was given to 97% patients along with fluid administration, and 78% were found to be resistant to quinolones." | 1.38 | Clinical characteristics and predictors of positive stool culture in adult patients with acute gastroenteritis. ( Anwar, MA; Awan, S; Hilal, H; Khan, MS; Patel, MJ; Razi, S; Riaz, MM; Tariq, M, 2012) |
| "Ulifloxacin was highly active against Escherichia coli, Salmonella spp." | 1.35 | Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea. ( Biedenbach, DJ; Fritsche, TR; Jones, RN, 2009) |
| "Ciprofloxacin resistance was not associated with particularly severe infection." | 1.35 | Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates. ( Feodoroff, FB; Hänninen, ML; Lauhio, AR; Rautelin, HI; Sarna, SJ, 2009) |
| "The proven shigellosis as well as the strong suspicion have to be treated promptly with antibiotics, mainly azithromycin." | 1.35 | [Bacterial diarrheas and antibiotics: European recommendations]. ( Cohen, R; Gendrel, D, 2008) |
| "Rifaximin has been evaluated in adults for treatment of bacterial enteritis and has a good record for safety and efficacy, but it has not been evaluated extensively in children with gastroenteritis." | 1.34 | Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli. ( Chen, J; Cleary, TG; Gonzales, E; Ochoa, TJ; Walker, CM, 2007) |
| "military personnel being treated for diarrhea were evaluated." | 1.33 | Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin. ( Frenck, RW; Putnam, SD; Riddle, MS; Rockabrand, DR; Rozmajzl, PJ; Sanders, JW; Tribble, DR, 2005) |
| "Ciprofloxacin resistance was detected in 1% of ETEC isolates in 1994 and 1995 and in one of 349 nontyphoidal Salmonella isolates in 1995." | 1.30 | Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. ( Echeverria, P; Gambel, JM; Hoge, CW; Pitarangsi, C; Srijan, A, 1998) |
| "Oral ciprofloxacin therapy was continued for 10 days and the patient remained free of symptoms with formed stools thereafter." | 1.29 | Pseudomonas aeruginosa as a cause of infectious diarrhea successfully treated with oral ciprofloxacin. ( Porco, FV; Visconte, EB, 1995) |
| "Ciprofloxacin is an uncommon cause of pseudomembranous colitis." | 1.28 | Ciprofloxacin as a cause of Clostridium difficile-associated diarrhoea in an HIV antibody-positive patient. ( Harris, JR; Hillman, RJ; Rao, GG; Taylor-Robinson, D, 1990) |
| "Ciprofloxacin was used successfully in two outbreaks of salmonella gastroenteritis at a dose of 500 mg bd orally for seven days." | 1.28 | Management of institutional outbreaks of Salmonella gastroenteritis. ( Ahmad, F; Cowden, J; Lightfoot, NF, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (5.76) | 18.7374 |
| 1990's | 61 (31.94) | 18.2507 |
| 2000's | 48 (25.13) | 29.6817 |
| 2010's | 57 (29.84) | 24.3611 |
| 2020's | 14 (7.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ochoa, TJ | 1 |
| Chen, J | 1 |
| Walker, CM | 1 |
| Gonzales, E | 1 |
| Cleary, TG | 1 |
| Fritsche, TR | 1 |
| Biedenbach, DJ | 1 |
| Jones, RN | 1 |
| Motamedi, H | 1 |
| Fathollahi, M | 1 |
| Abiri, R | 1 |
| Kadivarian, S | 1 |
| Rostamian, M | 1 |
| Alvandi, A | 1 |
| Osei-Owusu, H | 1 |
| Kudera, T | 1 |
| Strakova, M | 1 |
| Rondevaldova, J | 1 |
| Skrivanova, E | 1 |
| Novy, P | 1 |
| Kokoska, L | 1 |
| Nuzhat, S | 3 |
| Das, R | 3 |
| Das, S | 3 |
| Islam, SB | 3 |
| Palit, P | 3 |
| Haque, MA | 3 |
| Chakraborty, S | 6 |
| Khan, SH | 3 |
| Ahmed, D | 4 |
| Alam, B | 3 |
| Ahmed, T | 3 |
| Chisti, MJ | 3 |
| Faruque, ASG | 3 |
| Le Dault, E | 1 |
| Sicard, S | 1 |
| Desplans, J | 1 |
| Mayet, A | 1 |
| Simon, F | 1 |
| Aigle, L | 1 |
| Savini, H | 1 |
| Coton, T | 1 |
| Marimoutou, C | 1 |
| DuPont, HL | 11 |
| Almenoff, JS | 1 |
| Jamindar, MS | 1 |
| Bortey, E | 1 |
| Steffen, R | 6 |
| Kasumba, IN | 1 |
| Badji, H | 1 |
| Powell, H | 1 |
| Hossain, MJ | 1 |
| Omore, R | 1 |
| Sow, SO | 1 |
| Verani, JR | 1 |
| Platts-Mills, JA | 1 |
| Widdowson, MA | 1 |
| Zaman, SMA | 1 |
| Jones, J | 1 |
| Sen, S | 1 |
| Permala-Booth, J | 1 |
| Nasrin, S | 1 |
| Roose, A | 1 |
| Nasrin, D | 1 |
| Ochieng, JB | 1 |
| Juma, J | 1 |
| Doh, S | 1 |
| Jones, JCM | 1 |
| Antonio, M | 1 |
| Awuor, AO | 1 |
| Sugerman, CE | 1 |
| Watson, N | 1 |
| Focht, C | 1 |
| Liu, J | 1 |
| Houpt, E | 1 |
| Kotloff, KL | 1 |
| Tennant, SM | 1 |
| Gastaldi Guerrieri, C | 1 |
| Teixeira Gonçalves, M | 1 |
| Ferreira da Silva, A | 1 |
| Souza Dos Santos, AL | 1 |
| Dos Santos, KV | 1 |
| Cruz Spano, L | 1 |
| Jansson-Knodell, CL | 1 |
| Shin, A | 1 |
| Rogers, N | 1 |
| Moharana, SS | 1 |
| Panda, RK | 1 |
| Dash, M | 1 |
| Chayani, N | 1 |
| Bokade, P | 1 |
| Pati, S | 1 |
| Bhattacharya, D | 1 |
| Ngogo, FA | 1 |
| Joachim, A | 1 |
| Abade, AM | 1 |
| Rumisha, SF | 1 |
| Mizinduko, MM | 1 |
| Majigo, MV | 1 |
| Antonitsch, L | 1 |
| Weidinger, G | 1 |
| Stanek, G | 1 |
| Markowicz, M | 1 |
| van Wietmarschen, HA | 1 |
| Busch, M | 1 |
| van Oostveen, A | 1 |
| Pot, G | 1 |
| Jong, MC | 1 |
| Espinoza, N | 1 |
| Rojas, J | 1 |
| Pollett, S | 1 |
| Meza, R | 2 |
| Patiño, L | 1 |
| Leiva, M | 1 |
| Camiña, M | 1 |
| Bernal, M | 1 |
| Reynolds, ND | 1 |
| Maves, R | 1 |
| Tilley, DH | 1 |
| Kasper, M | 1 |
| Simons, MP | 1 |
| Talaat, KR | 2 |
| Porter, CK | 2 |
| Jaep, KM | 1 |
| Duplessis, CA | 1 |
| Gutierrez, RL | 2 |
| Maciel, M | 1 |
| Adjoodani, B | 1 |
| Feijoo, B | 1 |
| Brubaker, J | 2 |
| Trop, SA | 1 |
| Riddle, MS | 6 |
| Joseph, SS | 1 |
| Bourgeois, AL | 3 |
| Prouty, MG | 1 |
| Sharifi, S | 1 |
| Bakhshi, B | 1 |
| Najar-Peerayeh, S | 1 |
| Miyamoto, Y | 1 |
| Udaka, K | 1 |
| Sekimoto, E | 1 |
| Shibata, H | 1 |
| Otsuka, K | 1 |
| Mori, K | 1 |
| Shigekiyo, T | 1 |
| Ozaki, S | 1 |
| Jiang, ZD | 6 |
| Edson, RS | 1 |
| Litin, SC | 1 |
| Bundrick, JB | 1 |
| Stoney, RJ | 1 |
| Han, PV | 1 |
| Barnett, ED | 1 |
| Wilson, ME | 1 |
| Jentes, ES | 1 |
| Benoit, CM | 1 |
| MacLeod, WB | 1 |
| Hamer, DH | 1 |
| Chen, LH | 1 |
| Tribble, DR | 4 |
| Huang, HC | 1 |
| Vlasova, AN | 1 |
| Kumar, A | 1 |
| Kandasamy, S | 1 |
| Fischer, DD | 1 |
| Deblais, L | 1 |
| Paim, FC | 1 |
| Langel, SN | 1 |
| Alhamo, MA | 1 |
| Rauf, A | 1 |
| Shao, L | 1 |
| Saif, LJ | 1 |
| Rajashekara, G | 1 |
| Rimmer, JE | 1 |
| Harro, C | 2 |
| Sack, DA | 2 |
| DeNearing, B | 1 |
| Laird, RM | 1 |
| Poly, F | 1 |
| Maue, AC | 1 |
| Jaep, K | 1 |
| Alcala, A | 1 |
| Mochalova, Y | 1 |
| Gariepy, CL | 1 |
| Guerry, P | 1 |
| Mohan, B | 1 |
| Sethuraman, N | 1 |
| Verma, R | 1 |
| Taneja, N | 1 |
| Baker, KS | 1 |
| Dallman, TJ | 1 |
| Field, N | 1 |
| Childs, T | 1 |
| Mitchell, H | 1 |
| Day, M | 1 |
| Weill, FX | 1 |
| Lefèvre, S | 1 |
| Tourdjman, M | 1 |
| Hughes, G | 1 |
| Jenkins, C | 1 |
| Thomson, N | 1 |
| Dawadi, S | 1 |
| Elhadidy, M | 1 |
| Miller, WG | 1 |
| Arguello, H | 1 |
| Álvarez-Ordóñez, A | 1 |
| Dierick, K | 1 |
| Botteldoorn, N | 1 |
| Schiaffino, F | 1 |
| Colston, JM | 1 |
| Paredes-Olortegui, M | 1 |
| François, R | 1 |
| Pisanic, N | 1 |
| Burga, R | 2 |
| Peñataro-Yori, P | 1 |
| Kosek, MN | 1 |
| Gracias Garcia, ML | 1 |
| Araujo, P | 1 |
| Stiess, M | 1 |
| Nacak, T | 1 |
| Greinwald, R | 1 |
| Connor, P | 1 |
| Kayman, T | 1 |
| Abay, S | 1 |
| Aydin, F | 1 |
| Şahin, O | 1 |
| Carlucci, C | 1 |
| Jones, CS | 1 |
| Oliphant, K | 1 |
| Yen, S | 1 |
| Daigneault, M | 1 |
| Carriero, C | 1 |
| Robinson, A | 2 |
| Petrof, EO | 1 |
| Weese, JS | 1 |
| Allen-Vercoe, E | 1 |
| Ericsson, CD | 6 |
| Connor, BA | 1 |
| Abbasi, E | 1 |
| van Belkum, A | 1 |
| Ghaznavi-Rad, E | 1 |
| Sreenivasan, P | 1 |
| Nujum, ZT | 1 |
| Purushothaman, KK | 1 |
| Gupta, NK | 1 |
| Masia, R | 1 |
| Tsang, OT | 1 |
| Wong, RW | 1 |
| Lam, BH | 1 |
| Chan, JM | 1 |
| Tsang, KY | 1 |
| Leung, WS | 1 |
| Benoit, SR | 1 |
| Lopez, B | 1 |
| Arvelo, W | 1 |
| Henao, O | 1 |
| Parsons, MB | 1 |
| Reyes, L | 1 |
| Moir, JC | 1 |
| Lindblade, K | 1 |
| Kaiser, P | 2 |
| Regoes, RR | 2 |
| Dolowschiak, T | 1 |
| Wotzka, SY | 1 |
| Lengefeld, J | 1 |
| Slack, E | 1 |
| Grant, AJ | 1 |
| Ackermann, M | 1 |
| Hardt, WD | 3 |
| Hill, DR | 1 |
| Mayer, K | 1 |
| Hahn-Ast, C | 1 |
| Mückter, S | 1 |
| Schmitz, A | 1 |
| Krause, S | 1 |
| Felder, L | 1 |
| Bekeredjian-Ding, I | 1 |
| Molitor, E | 1 |
| Brossart, P | 1 |
| von Lilienfeld-Toal, M | 1 |
| Erdemli, Ö | 1 |
| Timuroğlu, A | 1 |
| Oral, İ | 1 |
| Çekmen, N | 1 |
| Lübbert, C | 2 |
| Rocha-Castro, J | 1 |
| Kronbauer, K | 1 |
| Dallé, J | 1 |
| Jimenez, MF | 1 |
| Riche, CW | 1 |
| Santiago, JA | 1 |
| Antonello, VS | 1 |
| Odetoyin, BW | 1 |
| Hofmann, J | 1 |
| Aboderin, AO | 1 |
| Okeke, IN | 1 |
| Reuland, EA | 1 |
| Sonder, GJ | 1 |
| Stolte, I | 1 |
| Al Naiemi, N | 1 |
| Koek, A | 1 |
| Linde, GB | 1 |
| van de Laar, TJ | 1 |
| Vandenbroucke-Grauls, CM | 2 |
| van Dam, AP | 1 |
| Tian, L | 2 |
| Zhu, X | 1 |
| Chen, Z | 1 |
| Liu, W | 1 |
| Li, S | 3 |
| Yu, W | 1 |
| Zhang, W | 1 |
| Xiang, X | 2 |
| Sun, Z | 1 |
| Pop, M | 1 |
| Paulson, JN | 1 |
| Astrovskaya, I | 1 |
| Lindsay, BR | 1 |
| Bravo, HC | 1 |
| Parkhill, J | 1 |
| Walker, AW | 1 |
| Walker, RI | 1 |
| Stine, OC | 1 |
| Begum, YA | 1 |
| Talukder, KA | 1 |
| Azmi, IJ | 1 |
| Shahnaij, M | 1 |
| Sheikh, A | 1 |
| Sharmin, S | 1 |
| Svennerholm, AM | 1 |
| Qadri, F | 2 |
| Zhu, XH | 1 |
| Cheng, ZJ | 1 |
| Liu, WY | 1 |
| Yu, WT | 1 |
| Zhang, WQ | 1 |
| Sun, ZY | 1 |
| Mehla, K | 1 |
| Ramana, J | 1 |
| Bessalah, S | 1 |
| Fairbrother, JM | 1 |
| Salhi, I | 1 |
| Vanier, G | 1 |
| Khorchani, T | 1 |
| Seddik, MM | 1 |
| Hammadi, M | 1 |
| Dean, R | 1 |
| Gill, D | 1 |
| Buchan, D | 1 |
| Soonawala, D | 1 |
| Goorhuis, A | 1 |
| Roukens, A | 1 |
| Visser, L | 1 |
| Gendrel, D | 1 |
| Cohen, R | 1 |
| Feodoroff, FB | 1 |
| Lauhio, AR | 1 |
| Sarna, SJ | 1 |
| Hänninen, ML | 2 |
| Rautelin, HI | 1 |
| Opapeju, FO | 1 |
| Krause, DO | 2 |
| Payne, RL | 1 |
| Rademacher, M | 1 |
| Nyachoti, CM | 2 |
| Xue, H | 1 |
| Field, CJ | 1 |
| Sawyer, MB | 1 |
| Dieleman, LA | 1 |
| Baracos, VE | 1 |
| Taguchi, M | 1 |
| Kawahara, R | 1 |
| Seto, K | 1 |
| Inoue, K | 1 |
| Hayashi, A | 1 |
| Yamagata, N | 1 |
| Kamakura, K | 1 |
| Kashiwagi, E | 1 |
| Tillett, E | 1 |
| Loosemore, M | 1 |
| Samie, A | 1 |
| Guerrant, RL | 1 |
| Barrett, L | 1 |
| Bessong, PO | 1 |
| Igumbor, EO | 1 |
| Obi, CL | 1 |
| Layer, P | 1 |
| Andresen, V | 1 |
| Kreft, B | 1 |
| Oehme, A | 1 |
| Marsch, WC | 1 |
| Kekulé, AS | 1 |
| Govendir, M | 1 |
| Hansen, T | 1 |
| Kimble, B | 1 |
| Norris, JM | 1 |
| Baral, RM | 1 |
| Wigney, DI | 1 |
| Gottlieb, S | 1 |
| Malik, R | 1 |
| Shah, MB | 1 |
| Sundararajan, S | 1 |
| Crawford, CV | 1 |
| Hartono, C | 1 |
| Joshi, PV | 1 |
| Shirkhedkar, AA | 1 |
| Prakash, K | 1 |
| Maheshwari, VL | 1 |
| Usluca, S | 1 |
| Aksoy, U | 1 |
| Ouyang-Latimer, J | 1 |
| Jafri, S | 1 |
| VanTassel, A | 1 |
| Gurleen, K | 1 |
| Rodriguez, S | 1 |
| Nandy, RK | 1 |
| Ramamurthy, T | 2 |
| Chatterjee, S | 1 |
| McKenzie, R | 1 |
| Rosewell, A | 1 |
| Dagina, R | 1 |
| Murhekar, M | 1 |
| Ropa, B | 1 |
| Posanai, E | 1 |
| Dutta, S | 1 |
| Barr, I | 1 |
| Mola, G | 1 |
| Zwi, A | 1 |
| MacIntyre, CR | 1 |
| Rahouma, A | 1 |
| Klena, JD | 1 |
| Krema, Z | 1 |
| Abobker, AA | 1 |
| Treesh, K | 1 |
| Franka, E | 1 |
| Abusnena, O | 1 |
| Shaheen, HI | 1 |
| El Mohammady, H | 1 |
| Abudher, A | 1 |
| Ghenghesh, KS | 1 |
| Riaz, MM | 1 |
| Patel, MJ | 1 |
| Khan, MS | 1 |
| Anwar, MA | 1 |
| Tariq, M | 1 |
| Hilal, H | 1 |
| Awan, S | 1 |
| Razi, S | 1 |
| Endt, K | 1 |
| Maier, L | 1 |
| Käppeli, R | 1 |
| Barthel, M | 1 |
| Misselwitz, B | 1 |
| Kremer, M | 1 |
| Mandisodza, O | 1 |
| Burrows, E | 1 |
| Nulsen, M | 1 |
| Zaidi, MB | 1 |
| McDermott, PF | 1 |
| Campos, FD | 1 |
| Chim, R | 1 |
| Leon, M | 1 |
| Vazquez, G | 1 |
| Figueroa, G | 1 |
| Lopez, E | 1 |
| Contreras, J | 1 |
| Estrada-Garcia, T | 1 |
| Geerdes-Fenge, HF | 1 |
| Löbermann, M | 1 |
| Nürnberg, M | 1 |
| Fritzsche, C | 1 |
| Koball, S | 1 |
| Henschel, J | 1 |
| Höhn, R | 1 |
| Schober, HC | 1 |
| Mitzner, S | 1 |
| Podbielski, A | 1 |
| Reisinger, EC | 1 |
| Jarfaut, A | 1 |
| Santucci, R | 1 |
| Levêque, D | 1 |
| Herbrecht, R | 1 |
| Leung, DT | 1 |
| Das, SK | 1 |
| Malek, MA | 1 |
| Khanam, F | 1 |
| Faruque, AS | 1 |
| Ryan, ET | 1 |
| Kiarie, E | 1 |
| Scott, M | 1 |
| Khazanehei, H | 1 |
| Khafipour, E | 1 |
| Thomas, C | 1 |
| Golledge, CL | 3 |
| Riley, TV | 3 |
| Hoelscher, M | 1 |
| Löscher, T | 1 |
| Day, LJ | 1 |
| Golden, W | 1 |
| Lannen, L | 1 |
| Engleberg, NC | 1 |
| Putnam, SD | 2 |
| Frenck, RW | 2 |
| El-Gendy, A | 1 |
| Taha, NN | 1 |
| Pittner, BT | 1 |
| Abu-Elyazeed, R | 1 |
| Wierzba, TF | 1 |
| Rao, MR | 1 |
| Savarino, SJ | 1 |
| Clemens, JD | 1 |
| Jones, FR | 1 |
| Sanchez, JL | 3 |
| Batsel, TM | 1 |
| Canal, E | 1 |
| Block, K | 1 |
| Perez, J | 1 |
| Bautista, CT | 1 |
| Escobedo, J | 1 |
| Walz, SE | 1 |
| Nelson, JM | 1 |
| Smith, KE | 1 |
| Vugia, DJ | 1 |
| Rabatsky-Ehr, T | 1 |
| Segler, SD | 1 |
| Kassenborg, HD | 1 |
| Zansky, SM | 1 |
| Joyce, K | 1 |
| Marano, N | 1 |
| Hoekstra, RM | 1 |
| Angulo, FJ | 1 |
| Sinha, S | 1 |
| Chattopadhyay, S | 1 |
| Bhattacharya, SK | 2 |
| Nair, GB | 1 |
| Cárcamo, C | 1 |
| Hooton, T | 1 |
| Wener, MH | 1 |
| Weiss, NS | 1 |
| Gilman, R | 1 |
| Arevalo, J | 1 |
| Carrasco, J | 1 |
| Seas, C | 2 |
| Caballero, M | 1 |
| Holmes, KK | 1 |
| Sanders, JW | 1 |
| Rockabrand, DR | 1 |
| Rozmajzl, PJ | 1 |
| Bischoff, A | 1 |
| Takayama, S | 1 |
| Satake, S | 1 |
| Ishihara, K | 1 |
| Ismaeel, AY | 1 |
| Senok, AC | 1 |
| Bindayna, KM | 1 |
| Bakhiet, M | 1 |
| Al Mahmeed, A | 1 |
| Yousif, AQ | 1 |
| Botta, GA | 1 |
| Borrows, R | 1 |
| Chusney, G | 1 |
| James, A | 1 |
| Stichbury, J | 1 |
| Van Tromp, J | 1 |
| Cairns, T | 1 |
| Griffith, M | 1 |
| Hakim, N | 1 |
| McLean, A | 1 |
| Palmer, A | 1 |
| Papalois, V | 1 |
| Taube, D | 1 |
| Reda, E | 1 |
| Mansell, C | 1 |
| Fourcroy, JL | 1 |
| Berner, B | 1 |
| Chiang, YK | 1 |
| Cramer, M | 1 |
| Rowe, L | 1 |
| Shore, N | 1 |
| Keenum, AJ | 1 |
| Stockton, MD | 1 |
| Mazumder, R | 1 |
| Bhattacharya, S | 1 |
| Mazumder, A | 1 |
| Pattnaik, AK | 1 |
| Tiwary, PM | 1 |
| Chaudhary, S | 1 |
| Bos, JC | 1 |
| Schultsz, C | 1 |
| Speelman, P | 1 |
| Prins, JM | 1 |
| Saha, D | 1 |
| Karim, MM | 1 |
| Khan, WA | 1 |
| Ahmed, S | 1 |
| Salam, MA | 1 |
| Bennish, ML | 1 |
| Taylor, DN | 4 |
| Halpern, J | 1 |
| Haake, R | 1 |
| Pal, BB | 1 |
| Khuntia, HK | 1 |
| Samal, SK | 1 |
| Das, SS | 1 |
| Chhotray, GP | 1 |
| Sonnevend, Á | 1 |
| Rotimi, VO | 1 |
| Kolodziejek, J | 1 |
| Usmani, A | 1 |
| Nowotny, N | 1 |
| Pál, T | 1 |
| Navarro-Llavat, M | 1 |
| Domènech, E | 1 |
| Masnou, H | 1 |
| Ojanguren, I | 1 |
| Mañosa, M | 1 |
| Lorenzo-Zúñiga, V | 1 |
| Boix, J | 1 |
| Gassull, MA | 1 |
| Eja, ME | 1 |
| Asikong, BE | 1 |
| Abriba, C | 1 |
| Arikpo, GE | 1 |
| Anwan, EE | 1 |
| Enyi-Idoh, KH | 1 |
| Alonso, D | 1 |
| Muñoz, J | 1 |
| Ruiz, J | 1 |
| Carmona, F | 1 |
| Nadal, A | 1 |
| Gascón, J | 1 |
| Wardak, S | 1 |
| Szych, J | 1 |
| Duda, U | 1 |
| Rautelin, H | 1 |
| Sivonen, A | 1 |
| Turunen, U | 1 |
| Valtonen, V | 1 |
| Echevarría, J | 1 |
| Carrillo, C | 1 |
| Mostorino, R | 1 |
| Ruiz, R | 1 |
| Gotuzzo, E | 1 |
| Reina, J | 1 |
| Ros, MJ | 1 |
| Fernandez-Baca, V | 1 |
| Kaminski, N | 1 |
| Bogomolski, V | 1 |
| Stalnikowicz, R | 1 |
| Cid, D | 1 |
| Piriz, S | 1 |
| Ruiz-Santa-Quiteria, JA | 1 |
| Valle, J | 1 |
| Garcia, S | 1 |
| Vadillo, S | 1 |
| de la Fuente, R | 1 |
| Fiore, DC | 1 |
| Connor, MP | 1 |
| Green, AD | 1 |
| Hall, C | 1 |
| Cornell, J | 1 |
| Maher, D | 1 |
| Harries, AD | 1 |
| Tomayko, JF | 1 |
| Korten, V | 1 |
| Murray, BE | 1 |
| Keystone, JS | 1 |
| Salam, I | 1 |
| Katelaris, P | 1 |
| Leigh-Smith, S | 1 |
| Farthing, MJ | 1 |
| Parry, H | 1 |
| Howard, AJ | 1 |
| Galpin, OP | 1 |
| Hassan, SP | 1 |
| O'Keeffe, BJ | 2 |
| Schwartz, D | 1 |
| Goossens, H | 1 |
| Levy, J | 1 |
| Butzler, JP | 1 |
| Goldhar, J | 1 |
| Louie, TJ | 1 |
| Murphy, GS | 3 |
| Bodhidatta, L | 1 |
| Echeverria, P | 6 |
| Tansuphaswadikul, S | 1 |
| Hoge, CW | 3 |
| Imlarp, S | 1 |
| Tamura, K | 1 |
| Kuschner, RA | 1 |
| Trofa, AF | 1 |
| Thomas, RJ | 1 |
| Pitarangsi, C | 3 |
| Amato, S | 1 |
| Olafson, RP | 1 |
| Sadoff, JC | 1 |
| Porco, FV | 1 |
| Visconte, EB | 1 |
| Sharpstone, D | 1 |
| Gazzard, B | 1 |
| Jackson, LR | 1 |
| Arness, MK | 1 |
| LeBron, C | 1 |
| Dryden, MS | 1 |
| Gabb, RJ | 1 |
| Wright, SK | 1 |
| Laing, RB | 1 |
| Lee, C | 1 |
| Leen, CL | 1 |
| Beckebaum, S | 1 |
| Bircher, J | 1 |
| Gallenkamp, H | 1 |
| Tadano, K | 1 |
| Shingaki, M | 1 |
| Saito, K | 1 |
| Takahashi, M | 1 |
| Kai, A | 1 |
| Yanagawa, Y | 1 |
| Itoh, T | 1 |
| Ohta, K | 1 |
| Kudoh, Y | 1 |
| Bruce-Jones, PN | 1 |
| Allen, SC | 1 |
| Zabala López, S | 2 |
| Castiella Herrero, J | 1 |
| Cid Gil, C | 1 |
| Juyol Rodrigo, MC | 1 |
| Gracia Sánchez, P | 1 |
| Jones, EM | 1 |
| Kirkpatrick, BL | 1 |
| Feeney, R | 1 |
| Reeves, DS | 1 |
| MacGowan, AP | 1 |
| Ala'Aldeen, DA | 1 |
| Carter, A | 1 |
| Knott, L | 1 |
| Kennedy, T | 1 |
| Oyofo, BA | 1 |
| Peruski, LF | 1 |
| Ismail, TF | 1 |
| el-Etr, SH | 1 |
| Churilla, AM | 1 |
| Wasfy, MO | 1 |
| Petruccelli, BP | 2 |
| Gabriel, ME | 1 |
| Bauwens, JE | 1 |
| McFarland, LV | 1 |
| Melcher, SA | 1 |
| James, AH | 1 |
| Katz, VL | 1 |
| Dotters, DJ | 1 |
| Rogers, RG | 1 |
| Parkes, G | 1 |
| Gambel, JM | 1 |
| Srijan, A | 1 |
| Dutta, P | 1 |
| Mitra, U | 1 |
| Rasaily, R | 1 |
| Saha, MR | 1 |
| Manna, B | 1 |
| Chatterjee, MK | 1 |
| Garai, T | 1 |
| Sengupta, M | 1 |
| Davis, AJ | 1 |
| Kolios, G | 1 |
| Alveyn, CG | 1 |
| Robertson, DA | 1 |
| Over, KE | 1 |
| Bucknall, RC | 1 |
| Wanke, CA | 1 |
| Gerrior, J | 1 |
| Blais, V | 1 |
| Mayer, H | 1 |
| Acheson, D | 1 |
| Paluszkiewicz, P | 1 |
| Karski, M | 1 |
| Misztal, M | 1 |
| Karski, J | 1 |
| Glandt, M | 1 |
| Adachi, JA | 2 |
| Mathewson, JJ | 2 |
| DiCesare, D | 1 |
| Ashley, D | 2 |
| Kaufman, JP | 1 |
| Carp, NZ | 1 |
| Livornese, LL | 1 |
| Verdier, RI | 1 |
| Fitzgerald, DW | 1 |
| Johnson, WD | 1 |
| Pape, JW | 1 |
| Iglesias Quirós, E | 1 |
| González Heras, S | 1 |
| Martínez Navarro, C | 1 |
| Gambaro Royo, B | 1 |
| Leibovitz, E | 1 |
| Janco, J | 1 |
| Piglansky, L | 1 |
| Press, J | 1 |
| Yagupsky, P | 1 |
| Reinhart, H | 1 |
| Yaniv, I | 1 |
| Dagan, R | 1 |
| Afset, JE | 1 |
| Maeland, JA | 1 |
| Oldfield, EC | 1 |
| Wallace, MR | 1 |
| DuPont, MW | 1 |
| Palazzini, E | 1 |
| Riopel, LM | 1 |
| Martinez-Sandoval, F | 1 |
| Acheson, DW | 1 |
| Sears, CL | 1 |
| Stahlmann, R | 1 |
| Panigrahi, H | 1 |
| Cartmill, TD | 1 |
| Nathwani, D | 1 |
| Wood, MJ | 2 |
| Carson, CF | 2 |
| O'Neill, GL | 1 |
| Bowman, RA | 2 |
| Wiström, J | 1 |
| Gentry, LO | 1 |
| Palmgren, AC | 1 |
| Price, M | 1 |
| Nord, CE | 1 |
| Ljungh, A | 1 |
| Norrby, SR | 1 |
| Walz, S | 2 |
| DeFraites, R | 1 |
| Gelnett, J | 1 |
| Haberberger, RL | 1 |
| Ahmad, F | 2 |
| Bray, G | 1 |
| Prescott, RW | 1 |
| Aquilla, S | 1 |
| Lightfoot, NF | 2 |
| Manzione, NC | 1 |
| Rademaker, CM | 2 |
| Krul, MR | 1 |
| Jansen, WH | 1 |
| Vos, NM | 1 |
| Hoepelman, IM | 2 |
| Rozenberg-Arska, M | 2 |
| Verhoef, J | 2 |
| Candler, W | 1 |
| Thornton, S | 1 |
| McQueen, C | 1 |
| Goodman, LJ | 1 |
| Trenholme, GM | 1 |
| Kaplan, RL | 1 |
| Segreti, J | 1 |
| Hines, D | 1 |
| Petrak, R | 1 |
| Nelson, JA | 1 |
| Mayer, KW | 1 |
| Landau, W | 1 |
| Parkhurst, GW | 1 |
| Hillman, RJ | 1 |
| Rao, GG | 1 |
| Harris, JR | 1 |
| Taylor-Robinson, D | 1 |
| Cowden, J | 1 |
| Pithie, AD | 1 |
| Bryan, JP | 1 |
| Waters, C | 1 |
| Sheffield, J | 1 |
| Krieg, RE | 1 |
| Perine, PL | 1 |
| Wagner, K | 1 |
| Hamer, IE | 1 |
| Olczak, SA | 1 |
| Parkin, D | 1 |
| Wolfhagen, MJ | 1 |
| Beumer, H | 1 |
| Inagaki, Y | 1 |
| Horiuchi, S | 1 |
| Une, T | 1 |
| Nakaya, R | 1 |
| Neu, HC | 1 |
| O'Hare, MD | 1 |
| Felmingham, D | 1 |
| Ridgway, GL | 1 |
| Grüneberg, RN | 1 |
| Pichler, H | 2 |
| Diridl, G | 3 |
| Wolf, D | 3 |
| Lettau, LA | 1 |
| Mikhail, IA | 1 |
| Hyams, KC | 1 |
| Podgore, JK | 1 |
| Lissner, CR | 1 |
| Stickler, K | 2 |
| Johnson, PC | 2 |
| Morgan, DR | 1 |
| Bitsura, JA | 1 |
| de la Cabada, FJ | 1 |
| Pichler, HE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Incidence and Burden of Shigella Diarrhea in Children Aged 6-35 Months: the Enterics for Global Health (EFGH) - Shigella Burden Study[NCT06047821] | 9,800 participants (Anticipated) | Observational | 2022-08-25 | Recruiting | |||
| Double Blind, Placebo-Controlled Trial Assessing the Efficacy of Rifaximin in Preventing Campylobacteriosis in Subjects Challenged With Campylobacter Jejuni[NCT02280044] | Phase 2/Phase 3 | 30 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
| Randomized, Double-Blind, Controlled Clinical Trial to Compare Efficacy of a Single Dose of Azithromycin Versus a Single Dose of Ciprofloxacin in the Treatment of Adults With Clinically Severe Cholera Due to V. Cholerae O1 or O139[NCT00229944] | Phase 3 | 220 participants | Interventional | 2002-12-31 | Completed | ||
| A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Two-Part Trial to Evaluate the Efficacy, Safety, and Tolerability of iOWH032 in the Treatment of Acute Dehydrating Diarrhea in Adult and Pediatric Patients With Cholera[NCT02111304] | Phase 2 | 0 participants (Actual) | Interventional | 2014-06-30 | Withdrawn (stopped due to Trial was never initiated due to PATH executive decision.) | ||
| A Randomized, Double-Blind, Single Center, Comparative Dose Ranging Study of Rifaximin Vs. Placebo in the Prevention of Travelers' Diarrhea Due to Enteropathogenic Bacteria[NCT00098384] | Phase 2 | 220 participants | Interventional | 2003-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"A clinical illness meeting at least one of the following patterns:~Moderate to severe diarrhea.~Fever (present on at least 2 occasions, at least 20 minutes apart) without diarrhea, plus an associated symptom (nausea, vomiting, abdominal cramps, tenesmus, or gross blood in ≥ 2 stools); with consideration of potential alternative diagnosis per clinical investigator based on illness time course and associated symptoms." (NCT02280044)
Timeframe: 120 hours after challenge
| Intervention | Participants (Count of Participants) |
|---|---|
| Rifaximin | 13 |
| Placebo | 11 |
Recovered C jejuni from fecal specimen on follow-up after an apparent cure (NCT02280044)
Timeframe: 84 Days
| Intervention | Participants (Count of Participants) |
|---|---|
| Rifaximin | 2 |
| Placebo | 3 |
13 reviews available for ciprofloxacin and Diarrhea
| Article | Year |
|---|---|
A worldwide systematic review and meta-analysis of bacteria related to antibiotic-associated diarrhea in hospitalized patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chloramphenicol; Ciprofloxacin; Clostridioide | 2021 |
Hematopoietic neoplasms accompanied by severe enterocolitis due to Aeromonas species.
Topics: Aeromonas; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Ciprofloxacin; Diarrhea; Enterocoliti | 2017 |
Etiology of travellers' diarrhea.
Topics: Anti-Bacterial Agents; Campylobacter; Ciprofloxacin; Diarrhea; DNA, Bacterial; Drug Resistance, Micr | 2017 |
Traveler's diarrhea: a clinical review.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Humans; Hygiene; Irritable Bowel Syndr | 2015 |
Antimicrobial therapy of acute diarrhoea: a clinical review.
Topics: Acute Disease; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campyloba | 2016 |
Setting standards for the prevention and management of travellers' diarrhoea in elite athletes: an audit of one team during the Youth Commonwealth Games in India.
Topics: Adolescent; Anti-Infective Agents; Athletes; Ciprofloxacin; Clinical Protocols; Diarrhea; England; H | 2009 |
Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea.
Topics: Administration, Oral; Anti-Infective Agents; Antidiarrheals; Ciprofloxacin; Diarrhea; Humans; Lopera | 2010 |
[Optimising antibiotic policies in the Netherlands. IX. SWAB guidelines for antimicrobial therapy in adults with acute infectious diarrhoea].
Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Dysentery; Erythromycin | 2006 |
Collagenous duodeno-ileo-colitis with transient IgG deficiency preceded by Yersinia enterocolitica intestinal infection: case report and review of literature.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Budesonide; Chronic Disease; Ciprofloxacin; Colitis | 2007 |
Gastrointestinal manifestations of HIV infection.
Topics: AIDS-Related Opportunistic Infections; Animals; Cachexia; Ciprofloxacin; Diarrhea; Gastrointestinal | 1996 |
The role of antibiotics in the treatment of infectious diarrhea.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Ciprofloxacin; Clostridi | 2001 |
Treatment of typhoid fever and infectious diarrhoea with ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Humans; Salmonella Infections; Salmonella typhi; Tim | 1990 |
Current problems in antimicrobial therapy for bacterial enteric infection.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Drug Combinations; Drug Re | 1987 |
37 trials available for ciprofloxacin and Diarrhea
| Article | Year |
|---|---|
A single dose of ciprofloxacin reduces the duration of diarrhea among service members deployed in Africa.
Topics: Africa; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Fever; Humans | 2023 |
Development of a new travellers' diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy.
Topics: Ciprofloxacin; Diarrhea; Double-Blind Method; Humans; Rifamycins; Travel | 2023 |
Probiotics use for antibiotic-associated diarrhea: a pragmatic participatory evaluation in nursing homes.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cipro | 2020 |
Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial.
Topics: Adolescent; Adult; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Load; Bacterial Toxins; Cip | 2020 |
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Campylobacter Infections; Campylobacter jejuni; Chemopre | 2018 |
Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Drug Resistance, Multip | 2018 |
Effect of dietary protein level on growth performance, indicators of enteric health, and gastrointestinal microbial ecology of weaned pigs induced with postweaning colibacillosis.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Ciprofloxac | 2009 |
Interactions of Saccharomyces cerevisiae fermentation product and in-feed antibiotic on gastrointestinal and immunological responses in piglets challenged with Escherichia coli K88+.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Diet; Drug Resistance, Bacteri | 2012 |
Determinants of mycophenolic acid levels after renal transplantation.
Topics: Adult; Alanine Transaminase; Amoxicillin-Potassium Clavulanate Combination; Biomarkers; Ciprofloxaci | 2005 |
Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Ci | 2005 |
Single-dose azithromycin for the treatment of cholera in adults.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cholera; Ciprofloxacin; Combined Modality Th | 2006 |
Single-dose azithromycin for the treatment of cholera in adults.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cholera; Ciprofloxacin; Combined Modality Th | 2006 |
Single-dose azithromycin for the treatment of cholera in adults.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cholera; Ciprofloxacin; Combined Modality Th | 2006 |
Single-dose azithromycin for the treatment of cholera in adults.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cholera; Ciprofloxacin; Combined Modality Th | 2006 |
A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Ciprofloxac | 2006 |
Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cholera; Ciprofloxacin; Diarrhea; Double-Blind Method | 1995 |
Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea.
Topics: Belize; Ciprofloxacin; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male | 1994 |
The prophylaxis of travellers' diarrhoea; a double blind placebo controlled trial of ciprofloxacin during a Himalayan expedition.
Topics: Altitude; Ciprofloxacin; Diarrhea; Double-Blind Method; Expeditions; Female; Humans; Male; Mountaine | 1994 |
Ciprofloxacin and loperamide in the treatment of bacillary dysentery.
Topics: Adult; Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Dysentery, Bacillary | 1993 |
Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Campylobacter; Campylobacter Infe | 1995 |
Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin.
Topics: Adult; Age Factors; Aged; Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Community- | 1996 |
Bioavailability of ciprofloxacin in patients with acute infectious diarrhoe.
Topics: Acute Disease; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Biological Availabilit | 1996 |
Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bile; C | 1998 |
Successful treatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Bacterial Adhesion; Ciprofloxacin; Cross-Over St | 1998 |
[Antibacterial treatment in patients after extended bowel resection with ileo-cecal valve removal--personal experience].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Diarrhea; Digest | 1998 |
Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Antidiarrheals; Ciprofloxacin; Diarrhea; Escherichia coli; Escherichia | 1999 |
Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Infective Agents; Chronic Di | 2000 |
Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Infective Agents; Ceftriaxone; Cephalosporins; | 2000 |
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Double-Blind Method; Feces; Femal | 2001 |
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Double-Blind Method; Feces; Femal | 2001 |
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Double-Blind Method; Feces; Femal | 2001 |
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Double-Blind Method; Feces; Femal | 2001 |
Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea.
Topics: Administration, Oral; Adolescent; Adult; Bacteroides; Ciprofloxacin; Diarrhea; Double-Blind Method; | 1992 |
Treatment of traveler's diarrhea with ciprofloxacin and loperamide.
Topics: Campylobacter Infections; Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; D | 1992 |
Analysis of Escherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping.
Topics: Adult; Ciprofloxacin; Diarrhea; DNA Probes; Escherichia coli; Feces; Humans; Middle Aged; Serotyping | 1991 |
Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial.
Topics: Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Dysentery, Bacillary; Esche | 1991 |
Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults.
Topics: Adult; Bacterial Infections; Campylobacter fetus; Campylobacter Infections; Ciprofloxacin; Diarrhea; | 1990 |
Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea.
Topics: Adult; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Feces; Female; Humans | 1989 |
Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ci | 1986 |
Ciprofloxacin versus placebo in the treatment of acute bacterial diarrhea.
Topics: Acute Disease; Adult; Bacteria; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Diarr | 1987 |
Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.
Topics: Adult; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Drug Combinations; Hu | 1987 |
Current problems in antimicrobial therapy for bacterial enteric infection.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Drug Combinations; Drug Re | 1987 |
Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Campylobacter fetus; Campylobacter Infections; | 1987 |
142 other studies available for ciprofloxacin and Diarrhea
| Article | Year |
|---|---|
Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.
Topics: Anti-Infective Agents; Bacteriolysis; Child; Child, Preschool; Coliphages; Diarrhea; Escherichia col | 2007 |
Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea.
Topics: Anti-Bacterial Agents; Diarrhea; Dioxolanes; Fluoroquinolones; Gastroenteritis; Gram-Negative Bacter | 2009 |
Topics: Anti-Bacterial Agents; Antidiarrheals; Bacteria; Benzylisoquinolines; Bifidobacterium; Ciprofloxacin | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysen | 2022 |
Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Diarrhea; | 2023 |
Remarkable antibiofilm activity of ciprofloxacin, cefoxitin, and tobramycin, by themselves or in combination, against enteroaggregative Escherichia coli in vitro.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Ciprofloxacin; Diarrhea; Escherichia coli; E | 2023 |
Acute Diarrheal Illness.
Topics: Acute Disease; Adolescent; Ciprofloxacin; Colon; Diarrhea; Feces; Female; Heart Rate; Humans; Ileum; | 2020 |
Etiology of childhood diarrhoea among under five children and molecular analysis of antibiotic resistance in isolated enteric bacterial pathogens from a tertiary care hospital, Eastern Odisha, India.
Topics: Anti-Bacterial Agents; Bacterial Infections; Child, Preschool; Ciprofloxacin; Cross-Sectional Studie | 2019 |
Factors associated with Salmonella infection in patients with gastrointestinal complaints seeking health care at Regional Hospital in Southern Highland of Tanzania.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciproflo | 2020 |
Francisella tularensis as the cause of protracted fever.
Topics: Abdominal Pain; Anti-Bacterial Agents; Body Weight; Ceftriaxone; Ciprofloxacin; Cough; Diagnosis, Di | 2020 |
Validation of the T86I mutation in the gyrA gene as a highly reliable real time PCR target to detect Fluoroquinolone-resistant Campylobacter jejuni.
Topics: Amino Acid Substitution; Campylobacter Infections; Campylobacter jejuni; Child; Ciprofloxacin; Diarr | 2020 |
Significant contribution of the CmeABC Efflux pump in high-level resistance to ciprofloxacin and tetracycline in Campylobacter jejuni and Campylobacter coli clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; | 2021 |
Clinical Pearls in Infectious Diseases 2017.
Topics: Administration, Intravaginal; Adult; Aged; Anti-Bacterial Agents; Body Piercing; Campylobacter Infec | 2017 |
Travelers' Diarrhea and Other Gastrointestinal Symptoms Among Boston-Area International Travelers.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antidiarrheals; Azithromycin; Boston; Ciprofl | 2017 |
Antibiotic Therapy for Acute Watery Diarrhea and Dysentery.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Developing Countries; Diarrhea; Dysentery; Human | 2017 |
Effect of antibiotic, probiotic, and human rotavirus infection on colonisation dynamics of defined commensal microbiota in a gnotobiotic pig model.
Topics: Animals; Anti-Bacterial Agents; Bifidobacterium longum; Biodiversity; Ciprofloxacin; Colony Count, M | 2018 |
Speciation, clinical profile & antibiotic resistance in
Topics: Adolescent; Adult; Aeromonas; Cefotaxime; Child; Child, Preschool; Cholera; Ciprofloxacin; Diarrhea; | 2017 |
Genomic epidemiology of Shigella in the United Kingdom shows transmission of pathogen sublineages and determinants of antimicrobial resistance.
Topics: Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Dysentery, Bacillary; Humans; Phylogeny; Shigel | 2018 |
The Cipro conundrum: updated guidelines not completely translated to practice.
Topics: Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial | 2018 |
Molecular epidemiology and antimicrobial resistance mechanisms of Campylobacter coli from diarrhoeal patients and broiler carcasses in Belgium.
Topics: Animals; Anti-Bacterial Agents; Belgium; Campylobacter coli; Campylobacter Infections; Chickens; Cip | 2019 |
Antibiotic Resistance of
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter; Campylobacter jejuni; Ciprofloxacin; Diarrhea; D | 2019 |
Antibiotics for Travellers' Diarrhoea on Trial-is there a potential role for Rifamycin SV?
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Diarrhea; Humans; Rifamycins; Travel | 2019 |
Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Diarrhea; Disk | 2019 |
Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Ciprofloxacin; Clostridiales; Clostridi | 2019 |
When should travel medicine practitioners prescribe Rifamycin SV-MXX for self-treatment of travellers' diarrhoea?
Topics: Bacteria; Ciprofloxacin; Diarrhea; Humans; Rifamycins; Travel; Travel Medicine | 2019 |
Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers' diarrhoea: reply.
Topics: Bacteria; Ciprofloxacin; Diarrhea; Humans; Rifamycins; Travel | 2019 |
Quinolone and Macrolide-Resistant
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Child; Child, Preschool; Cipr | 2019 |
Clinical response to antibiotics among children with bloody diarrhea.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Humans; Infant; Retrospecti | 2013 |
Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Colitis; Cord Blood Stem Cell Transplantation; Crohn Di | 2013 |
Cyclospora infection in a young woman with human immunodeficiency virus in Hong Kong: a case report.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Colonoscopy; Cyclospora; Cyclosporiasis; Diarrhea; Fece | 2013 |
Burden of laboratory-confirmed Campylobacter infections in Guatemala 2008-2012: results from a facility-based surveillance system.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Campylobacter; Campylobacter I | 2014 |
Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cecum; Ciprofloxacin; Dendritic Cells; Diarrhea; Dru | 2014 |
Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infecti | 2015 |
Ciprofloxacin-induced severe thrombocytopenia.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Female; Humans; Middle Aged; Thrombocytopenia | 2015 |
Population Dynamics Analysis of Ciprofloxacin-Persistent S. Typhimurium Cells in a Mouse Model for Salmonella Diarrhea.
Topics: Animals; Ciprofloxacin; Dendritic Cells; Diarrhea; Disease Models, Animal; Humans; Lymph Nodes; Mice | 2016 |
Characteristics of bacterial acute diarrhea among women.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Brazil; Ceftriaxone; Ciprofloxacin; Cross-Sect | 2016 |
Diarrhoeagenic Escherichia coli in mother-child Pairs in Ile-Ife, South Western Nigeria.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Diarrhea; Dia | 2016 |
Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Asia; beta-Lactamases; Ciprofloxacin; Cohort Studies; Diarrhea; Drug R | 2016 |
Characteristics of bacterial pathogens associated with acute diarrhea in children under 5 years of age: a hospital-based cross-sectional study.
Topics: Anti-Infective Agents; Campylobacter jejuni; Child; Child Health Services; Child, Preschool; China; | 2016 |
Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment.
Topics: Adult; Ciprofloxacin; Diarrhea; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Feces | 2016 |
Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Enterotoxige | 2016 |
Viral and Bacterial Etiology of Acute Diarrhea among Children under 5 Years of Age in Wuhan, China.
Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Campylobacter; Child, Preschool; China; Ciproflo | 2016 |
Travelers' Diarrhea-Associated Enterotoxigenic Escherichia coli gyrA Mutants and Quinolone Antibiotic Affinity: A Molecular Dynamics Simulation and Residue Interaction Network Analysis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Developing Countries; Diarrhea; DNA Gyrase; Drug Design; Drug | 2016 |
Antimicrobial resistance and molecular characterization of virulence genes, phylogenetic groups of Escherichia coli isolated from diarrheic and healthy camel-calves in Tunisia.
Topics: Animals; Anti-Bacterial Agents; Camelus; Ciprofloxacin; Diarrhea; Drug Resistance, Multiple, Bacteri | 2016 |
Salmonella colitis as an unusual cause of elevated serum lipase.
Topics: Abdominal Pain; Anti-Bacterial Agents; Ciprofloxacin; Colitis; Diagnosis, Differential; Diarrhea; Hu | 2017 |
Vaccination against travellers' diarrhoea.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Humans; Severity of Illness Index; Travel; Vaccinati | 2008 |
[Bacterial diarrheas and antibiotics: European recommendations].
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campylobacter Infections; Campylobacter j | 2008 |
[Bacterially induced traveler's diarrhea. Local antibiosis effective without systemic effects].
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Diagnosis, Differential; Diarrhea; Feces; Fluid Ther | 2008 |
Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Campylobacter coli; Campylobacter | 2009 |
Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy.
Topics: Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents, Phytogenic; Camptothe | 2009 |
Plasmid-mediated quinolone resistance in Salmonella isolated from patients with overseas travelers' diarrhea in Japan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; DNA, Bacterial; Drug Resistance, Bacterial; Genes, B | 2009 |
Prevalence of intestinal parasitic and bacterial pathogens in diarrhoeal and non-diarroeal human stools from Vhembe district, South Africa.
Topics: Adult; Animals; Anti-Infective Agents; Bacteria; Ceftriaxone; Child; Ciprofloxacin; Cross-Sectional | 2009 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal | 2010 |
Susceptibility of rapidly growing mycobacteria isolated from cats and dogs, to ciprofloxacin, enrofloxacin and moxifloxacin.
Topics: Animals; Anti-Bacterial Agents; Australia; Aza Compounds; Cats; Ciprofloxacin; Diarrhea; Dogs; Enrof | 2011 |
Malakoplakia-induced diarrhea in a kidney transplant recipient.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colitis; Colonoscopy; Diarrhea; Endoscopy; Humans; Intestinal | 2010 |
Antidiarrheal activity, chemical and toxicity profile of Berberis aristata.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antidiarrheals; Berberine; Berberis; Ciproflox | 2011 |
[Microsporidium spp. infection in an immunocompromised child diagnosed by polymerase chain reaction].
Topics: Albendazole; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Diarrhea; Drug Therapy, Combina | 2010 |
In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Drug Resistance, Ba | 2011 |
Concurrent influenza and shigellosis outbreaks, Papua New Guinea, 2009.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Disease | 2011 |
Enteric pathogens associated with childhood diarrhea in Tripoli-Libya.
Topics: Aeromonas; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Diarrhea; Drug Resistance, Bacter | 2011 |
Clinical characteristics and predictors of positive stool culture in adult patients with acute gastroenteritis.
Topics: Acute Disease; Adult; Age Distribution; Campylobacter; Ciprofloxacin; Community-Acquired Infections; | 2012 |
Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not.
Topics: Adaptive Immunity; Administration, Oral; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; | 2012 |
Arcobacter species in diarrhoeal faeces from humans in New Zealand.
Topics: Adult; Aged; Ampicillin; Arcobacter; Child, Preschool; Ciprofloxacin; Diarrhea; Erythromycin; Feces; | 2012 |
Antimicrobial-resistant Campylobacter in the food chain in Mexico.
Topics: Abattoirs; Animals; Animals, Domestic; Anti-Bacterial Agents; Campylobacter; Campylobacter Infection | 2012 |
Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciproflo | 2013 |
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Ant | 2013 |
Non-typhoidal Salmonella gastroenteritis at a diarrheal hospital in Dhaka, Bangladesh, 1996-2011.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Bangladesh; Case-Control Studies; Child; Child, | 2013 |
Ciprofloxacin and Clostridium difficile--associated diarrhea.
Topics: Anti-Infective Agents; Australia; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; C | 2002 |
[Malaria--case report].
Topics: Adult; Anti-Infective Agents; Antidiarrheals; Antimalarials; Chloroquine; Ciprofloxacin; Diarrhea; E | 2003 |
Ciprofloxacin use and misuse in the treatment of travelers' diarrhea.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Female; Humans; Male; Michi | 2003 |
Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylobacter jej | 2003 |
Short report: High incidence of shigellosis among Peruvian soldiers deployed in the Amazon River basin.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Drug Resistance, B | 2004 |
Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Case-Contro | 2004 |
An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients.
Topics: Aeromonas; Anti-Infective Agents; Base Sequence; Ciprofloxacin; Diarrhea; DNA Gyrase; DNA Topoisomer | 2004 |
Etiologies and manifestations of persistent diarrhea in adults with HIV-1 infection: a case-control study in Lima, Peru.
Topics: Adult; Aeromonas; Animals; Anti-Infective Agents; Bacterial Infections; Campylobacter; Case-Control | 2005 |
Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Escherichia coli; | 2005 |
[Gastrointestinal infections. Economize with antibiotics!].
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Diarrhea; Gastroenteritis; Humans; Metronidazole | 2005 |
[Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli isolated from human diarrheic samples].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; D | 2005 |
Effect of antibiotic sub inhibitory concentration on cytolethal distending toxin production by Campylobacter jejuni.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Toxins; Campylobacter Infections; Campyloba | 2005 |
Myocarditis in a patient with Campylobacter infection.
Topics: Adult; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Chest Pain; Ciprofloxa | 2005 |
Rifaximin (Xifaxan) for traveler's diarrhea.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Gastrointestinal Agents; Humans; Randomized Controll | 2005 |
Antidiarrhoeal evaluation of Aegle Marmelos (Correa) Linn. root extract.
Topics: Aegle; Animals; Anti-Bacterial Agents; Antidiarrheals; Castor Oil; Ciprofloxacin; Colony Count, Micr | 2006 |
Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba causing outbreaks of cholera in Orissa, India.
Topics: Cholera; Ciprofloxacin; Diarrhea; Disease Outbreaks; Female; Humans; India; Male; Microbial Sensitiv | 2006 |
High level of ciprofloxacin resistance and its molecular background among Campylobacter jejuni strains isolated in the United Arab Emirates.
Topics: Anti-Infective Agents; Base Sequence; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; | 2006 |
A comparative assessment of the antimicrobial effects of garlic (Allium sativum) and antibiotics on diarrheagenic organisms.
Topics: Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diarr | 2007 |
Salmonella ovarian abscess following travel diarrhoea episode.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Diarrhea; Female; Humans; Ovar | 2007 |
[Antimicrobial susceptibilities of Campylobacter sp strains isolated from humans in 2005 to 2006 in Bielsko-Biala Region, Poland].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobac | 2007 |
Chronic diarrhea due to a single strain of Aeromonas caviae.
Topics: Aeromonas; Chronic Disease; Ciprofloxacin; Diarrhea; DNA, Bacterial; Feces; Gram-Negative Bacterial | 1995 |
[Single-dosage ciprofloxacin in the treatment of traveler's diarrhea].
Topics: Ciprofloxacin; Diarrhea; Humans; Time Factors; Travel | 1995 |
Resistance to erythromycin in fluoroquinolone-resistant Campylobacter jejuni strains isolated from human faeces.
Topics: Campylobacter Infections; Campylobacter jejuni; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Mul | 1995 |
Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Bacteri | 1994 |
In vitro activities of enoxacin, enrofloxacin, sparfloxacin, and ciprofloxacin against Escherichia coli strains isolated from diarrheic lambs and kids.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Diarrhea, Infantile; Enoxacin; Enrofloxacin | 1994 |
Travellers' diarrhoea and use of single-dose ciprofloxacin.
Topics: Ciprofloxacin; Diarrhea; Humans; Randomized Controlled Trials as Topic; Travel | 1995 |
Travellers' diarrhoea and use of single-dose ciprofloxacin.
Topics: Ciprofloxacin; Diarrhea; Humans; Military Personnel; Travel; United Kingdom | 1995 |
Travellers' diarrhoea and use of single-dose ciprofloxacin.
Topics: Ciprofloxacin; Diarrhea; Humans; Military Personnel; Travel; United Kingdom | 1995 |
Travellers' diarrhoea and use of single-dose ciprofloxacin.
Topics: Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Humans; Travel | 1995 |
DU-6859a, a new fluoroquinolone agent. Comparative in vitro activity against enteric pathogens and multiresistant outpatient Escherichia coli.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Drug Resistance, Multiple; Escherichia coli; Fluoroq | 1994 |
Single-dose antibiotic treatment for travellers' diarrhoea.
Topics: Ciprofloxacin; Diarrhea; Humans; Loperamide; Travel | 1994 |
Resistance to ciprofloxacin in Campylobacter spp.
Topics: Campylobacter; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Humans | 1993 |
Plasmid profiles and antimicrobial susceptibility of Campylobacter jejuni isolated from Israeli children with diarrhea.
Topics: Amoxicillin; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Child; Ciproflox | 1993 |
Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
Topics: Administration, Oral; Ciprofloxacin; Diarrhea; Gram-Negative Bacterial Infections; Humans; Respirato | 1994 |
Pseudomonas aeruginosa as a cause of infectious diarrhea successfully treated with oral ciprofloxacin.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Cross Infection | 1995 |
Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Campylobacter; Campylobacter Infections; | 1996 |
An audit of the clinical features and use of antimicrobials in adult diarrhoea.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Drug Utilization; Feces; Gastroenteritis; Hum | 1996 |
[Evolution of susceptibilities of Campylobacter jejuni isolated from diarrhoeal cases to fluoroquinolones in Tokyo].
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Hu | 1996 |
Variations of invasive Salmonella infection in elderly people.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Disease Susceptibility; Eng | 1996 |
[Ciprofloxacin and Clostridium difficile associated diarrhea].
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Diarrhea; Enterocolitis, Pseud | 1996 |
Hospital-acquired Clostridium difficile diarrhoea.
Topics: Anti-Infective Agents; Cefuroxime; Cephalosporins; Ciprofloxacin; Clostridioides difficile; Cross In | 1997 |
A microbiologist's guide to travellers abroad: do as I say not as I do.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Female; Humans; India; Male; | 1997 |
Gastrointestinal upset in a frequent traveller.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Gastrointestinal Diseases; Humans; Travel | 1997 |
Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria, Egypt.
Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Antigens, Bacterial; Bacterial Proteins; Blas | 1997 |
Recurrent Clostridium difficile disease following ciprofloxacin use.
Topics: Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Colonoscopy; Diarrhea; Enterocolitis | 1997 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; | 1997 |
Treating diarrhoea. Rehydration should have been emphasised.
Topics: Anti-Infective Agents; Antidiarrheals; Ciprofloxacin; Diarrhea; Fluid Therapy; Humans | 1997 |
Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Diarrhea; Drug Resistance | 1998 |
Multi-drug resistant typhoid fever with diarrhea.
Topics: Anti-Infective Agents; Anti-Infective Agents, Local; Child; Child, Preschool; Ciprofloxacin; Diarrhe | 1997 |
Advice for travelers.
Topics: Anti-Infective Agents; Antidiarrheals; Bacterial Vaccines; Cholera; Ciprofloxacin; Diarrhea; Diphthe | 1998 |
Regression of skin changes in a patient with systemic sclerosis following treatment for bacterial overgrowth with ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Female; Humans; Middle Aged; Scleroderma, Systemic; | 1998 |
Re: Clinical characteristics and antibiotic utilization in surgical patients with Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Diarrhea; Ent | 2000 |
Case problem: medical nutrition therapy for a patient with Crohn's disease.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Body Weight; Ciprofloxacin; Crohn Disease; Diarrhea | 2000 |
[Diarrhea associated with Clostridium difficile secondary to the use of ciprofloxacin, complicating a first occurrence of intestinal inflammatory disease].
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Huma | 2000 |
[Erythromycin and ciprofloxacin resistant Campylobacter jejuni].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Ciprof | 2001 |
Dangers of empiric oral ciprofloxacin in the treatment of acute inflammatory diarrhea in children.
Topics: Acute Disease; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Empiricism; | 2001 |
Advice for travelers.
Topics: Africa; Altitude Sickness; Asia; Chloroquine; Ciprofloxacin; Contraindications; Diarrhea; Female; He | 2002 |
Clinical toxicological aspects of fluoroquinolones.
Topics: Anti-Infective Agents; Bacterial Infections; Cardiovascular Diseases; Central Nervous System Disease | 2002 |
Relapse of Salmonella infection after ciprofloxacin.
Topics: Aged; Carrier State; Ciprofloxacin; Diarrhea; Female; Humans; Recurrence; Salmonella Infections; Sal | 1992 |
Ciprofloxacin and Salmonella carriage.
Topics: Carrier State; Ciprofloxacin; Diarrhea; Feces; Humans; Recurrence; Salmonella; Salmonella Infections | 1992 |
Ciprofloxacin and Clostridium difficile-associated diarrhoea.
Topics: Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Diarrhea; Feces; Humans; Microbial | 1992 |
Ciprofloxacin in bacterial diarrhoea.
Topics: Bacterial Infections; Ciprofloxacin; Diarrhea; Humans | 1992 |
Use of ciprofloxacin to control a Salmonella outbreak in a long-stay psychiatric hospital.
Topics: Adult; Aged; Aged, 80 and over; Ciprofloxacin; Cross Infection; Diarrhea; Disease Outbreaks; Hospita | 1991 |
A note of caution on empiric use of ciprofloxacin for diarrhea.
Topics: Adult; Ciprofloxacin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans | 1992 |
Ciprofloxacin and pseudomembranous colitis.
Topics: Acute Disease; Ciprofloxacin; Clostridioides difficile; Contraindications; Diarrhea; Enterocolitis, | 1990 |
Ciprofloxacin and Clostridium difficile-associated diarrhoea.
Topics: Causality; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Culture Media; Cytotoxin | 1991 |
Ciprofloxacin as a cause of Clostridium difficile-associated diarrhoea in an HIV antibody-positive patient.
Topics: Adult; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Diarrhea; HIV Seropositivity | 1990 |
Management of institutional outbreaks of Salmonella gastroenteritis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Contraindications; Cross Infection; Diarrhea; Disease Outbreak | 1990 |
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Diarrhea; Fluoroquinolones; H | 1990 |
Mixed enteric infection.
Topics: Adult; Campylobacter Infections; Ciprofloxacin; Diarrhea; Dysentery, Bacillary; Egypt; Female; Human | 1990 |
In-vitro activity of DR-3355, an optically active isomer of ofloxacin, against bacterial pathogens associated with travellers' diarrhoea.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Diarrhea; Humans; Microbial Sensitivity Tests; Oflox | 1989 |
Clinical use of the quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Enoxacin; Gastrointestinal Diseases; Humans; Naphthy | 1987 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxaci | 1985 |
Oral fluoroquinolone therapy in Clostridium difficile enterocolitis.
Topics: Aged; Ceftriaxone; Ciprofloxacin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male | 1988 |
In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt.
Topics: Anti-Bacterial Agents; Campylobacter; Ciprofloxacin; Diarrhea; Drug Combinations; Drug Resistance, M | 1987 |